RSSS

+ Watchlist + Portfolio

Research Solutions, Inc

Recurring revenue Regulated industry Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $2.13
52-Week Range: $1.92 – $3.79
Market Cap: $72.59M
P/E (TTM): 23.89
EPS (TTM): 0.09
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 3.36
PEG Ratio: 1.38
Return on Equity: 16.30%
Return on Assets: 4.89%
Gross Margin: 51.90%
Operating Margin: 6.97%
Profit Margin: 5.84%
Current Ratio: 0.83
Debt/Equity: —
Total Debt: $0.00
Free Cash Flow: $2.88M
Revenue Growth: -2.90%
Earnings Growth: -72.40%
Enterprise Value: $57.53M

RSSS Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$32.93M	$37.70M	$44.62M	$49.06M	$48.31M
Cost of Revenue	$20.91M	$23.00M	$24.98M	$24.86M	$23.24M
Gross Profit	$12.02M	$14.70M	$19.64M	$24.20M	$25.07M
Research & Development	$3.71M	$3.74M	$5.44M	$5.63M	$6.12M
Selling, General & Admin	$9.78M	$10.79M	$14.11M	$15.02M	$14.05M
Operating Expenses	$13.51M	$14.58M	$20.39M	$21.90M	$22.47M
Operating Income	-$1.49M	$116.66K	-$748.15K	$2.30M	$2.60M
EBITDA	-$1.47M	$169.30K	$88.12K	$3.54M	$3.86M
Pretax Income	-$1.62M	$577.23K	-$3.67M	$1.35M	$2.96M
Income Tax	$7.62K	$5.60K	$113.07K	$82.81K	$133.04K
Net Income	-$1.63M	$571.62K	-$3.79M	$1.27M	$2.82M
Diluted EPS	-0.06	0.02	-0.13	0.04	0.09
Diluted Shares	26.42M	29.14M	28.86M	31.50M	32.27M

RSSS Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025	FY2026
Cash & Equivalents	$10.60M	$13.55M	$6.10M	$12.23M	$12.63M
Receivables	$5.25M	$6.15M	$6.88M	$7.19M	$6.96M
Current Assets	$16.98M	$21.30M	$14.69M	$20.00M	$20.69M
Total Assets	$17.03M	$21.83M	$41.86M	$46.12M	$45.66M
Current Liabilities	$12.14M	$14.50M	$17.87M	$25.51M	$24.94M
Total Liabilities	$12.14M	$14.50M	$30.17M	$32.19M	$24.96M
Retained Earnings	-$23.09M	-$22.52M	-$26.31M	-$25.04M	-$22.22M
Shareholders' Equity	$4.88M	$7.33M	$11.69M	$13.93M	$20.71M
Working Capital	$4.83M	$6.80M	-$3.18M	-$5.51M	-$4.25M

RSSS Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025	FY2026
Operating Cash Flow	-$417.20K	$3.38M	$3.55M	$7.02M	$5.27M
Capital Expenditure	-$44.29K	-$47.21K	-$71.51K	-$19.26K	-$39.77K
Free Cash Flow	-$461.49K	$3.34M	$3.48M	$7.00M	$5.23M
Depreciation & Amortisation	$17.65K	$52.65K	$836.27K	$1.25M	$1.25M
Investing Cash Flow	-$44.29K	-$344.66K	-$10.10M	-$19.26K	-$39.77K
Financing Cash Flow	$63.27K	-$97.26K	-$905.85K	-$877.88K	-$4.85M
Share Repurchases	-$93.92K	-$104.25K	-$554.20K	-$934.58K	-$53.04K
Net Change in Cash	-$398.22K	$2.94M	-$7.45M	$6.13M	$388.90K

RSSS Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$12.66M	$12.44M	$12.31M	$11.79M	$12.12M	$12.08M
Cost of Revenue	$6.39M	$6.10M	$6.09M	$5.62M	$5.86M	$5.68M
Gross Profit	$6.27M	$6.34M	$6.23M	$6.18M	$6.27M	$6.40M
Research & Development	$1.39M	$1.36M	$1.41M	$1.60M	$1.51M	$1.60M
Selling, General & Admin	$4.05M	$3.55M	$3.55M	$3.48M	$3.38M	$3.63M
Operating Expenses	$5.75M	$5.22M	$5.28M	$5.40M	$5.21M	$6.58M
Operating Income	$512.40K	$1.12M	$944.41K	$775.46K	$1.06M	-$174.61K
EBITDA	$541.89K	$1.44M	$1.26M	$1.09M	$1.44M	-$139.04K
Pretax Income	$229.88K	$2.37M	$770.62K	$555.78K	$882.37K	$746.34K
Income Tax	$13.41K	$8.00K	$21.23K	$8.86K	$22.17K	$80.78K
Net Income	$216.47K	$2.36M	$749.39K	$546.92K	$860.21K	$665.56K
Diluted EPS	0.01	—	0.02	0.02	0.03	—
Diluted Shares	32.14M	—	32.07M	32.33M	32.44M	—

RSSS Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$9.85M	$12.23M	$11.96M	$12.26M	$12.05M	$12.63M
Receivables	$7.60M	$7.19M	$6.90M	$5.66M	$7.60M	$6.96M
Current Assets	$18.84M	$20.00M	$19.66M	$18.67M	$20.68M	$20.69M
Total Assets	$45.23M	$46.12M	$45.51M	$44.24M	$45.95M	$45.66M
Current Liabilities	$24.90M	$25.51M	$24.88M	$23.61M	$25.10M	$24.94M
Total Liabilities	$34.00M	$32.19M	$29.92M	$27.02M	$26.89M	$24.96M
Retained Earnings	-$27.40M	-$25.04M	-$24.29M	-$23.75M	-$22.89M	-$22.22M
Shareholders' Equity	$11.23M	$13.93M	$15.59M	$17.23M	$19.06M	$20.71M
Working Capital	-$6.07M	-$5.51M	-$5.22M	-$4.94M	-$4.43M	-$4.25M

RSSS Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$2.89M	$2.26M	$1.11M	$1.38M	$1.01M	$1.78M
Capital Expenditure	-$6.17K	-$7.69K	-$17.54K	-$7.02K	-$4.05K	-$11.16K
Free Cash Flow	$2.89M	$2.25M	$1.09M	$1.38M	$1.00M	$1.76M
Depreciation & Amortisation	$312.01K	$315.02K	$316.07K	$316.43K	$312.40K	$310.08K
Investing Cash Flow	-$6.17K	-$7.69K	-$17.54K	-$7.02K	-$4.05K	-$11.16K
Financing Cash Flow	-$731.73K	$121.68K	-$1.36M	-$1.08M	-$1.22M	-$1.19M
Share Repurchases	-$703.12K	-$26.18K	-$23.39K	-$16.16K	-$7.84K	-$5.65K
Net Change in Cash	$2.15M	$2.37M	-$271.66K	$301.84K	-$215.78K	$574.51K

Market Snapshot

About

Research Solutions, Inc. provides cloud-based research intelligence solutions for life science and healthcare professionals. The company offers services that streamline the acquisition, management, and sharing of scientific content and data. Research Solutions serves pharmaceutical companies, biotech firms, academic institutions, and corporate research organizations.